trending Market Intelligence /marketintelligence/en/news-insights/trending/HMXQTdfRsBOfefebniTXNw2 content esgSubNav
In This List

Phylogica chief scientific officer resigns

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Phylogica chief scientific officer resigns

Phylogica Ltd. said Robert Hayes stepped down as the company's chief scientific officer, effective Dec. 24.

The company does not plan to name a replacement for Hayes in the near future.

Hayes has been acting as the company's chief scientific officer since June 2017.

Perth, Australia-based Phylogica provides drug discovery research and development services.